Mesenchymal stem cell and the method of use thereof
First Claim
Patent Images
1. A method for treating neurodegeneration, comprisinginjecting an effective amount of a cell population isolated from bone marrow or cord blood into a patient in need thereof, to treat neurodegeneration,wherein said isolated cell population comprises mesenchymal stem cells that are SH2(+), SH3(+), SH4(+), CD29(+), CD44(+), CD14(−
- ), CD34(−
), and CD45(−
), and does not exclude hematopoietic cells, andwherein cells within said injected cell population are capable of differentiating into neurons or glia cells.
0 Assignments
0 Petitions
Accused Products
Abstract
Demyelinated axons were remyelinated in the demyelinated rat model by collecting bone marrow cells from mouse bone marrow and transplanting the mononuclear cell fraction separated from these bone marrow cells.
-
Citations
14 Claims
-
1. A method for treating neurodegeneration, comprising
injecting an effective amount of a cell population isolated from bone marrow or cord blood into a patient in need thereof, to treat neurodegeneration, wherein said isolated cell population comprises mesenchymal stem cells that are SH2(+), SH3(+), SH4(+), CD29(+), CD44(+), CD14(− - ), CD34(−
), and CD45(−
), and does not exclude hematopoietic cells, andwherein cells within said injected cell population are capable of differentiating into neurons or glia cells. - View Dependent Claims (4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
- ), CD34(−
-
2. A method for treating neurodegeneration in a patient with a neurodegenerative disorder, which comprises injecting into a patient in need thereof, a mononuclear cell fraction comprising cells capable of differentiating into neurons or glia cells, wherein said fraction is prepared by
obtaining bone marrow cells or cord blood cells, diluting the bone marrow cells or cord blood cells, separating a mononuclear cell fraction, collecting said mononuclear cell fraction.
Specification